System for processing patient medical data for clinical trials and aggregate analysisA system processes medical information of multiple patients to provide data for use in supporting clinical decision making. The system includes an interface for receiving, from a remote source, data representing patient ...
The data have been acquired from several clinical centers including Rady... DETERMINE Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation, is a prospective, multicenter, randomized clinical trials in patients with coronary artery diseases and mild-to-moderate left ventricular dysfunction...
Electronic Data Collection system for clinical trials, specially designed for small and medium organizations: pharma, biotech companies, CROs, investigators.
The data have been acquired from several clinical centers including Rady... DETERMINE Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation, is a prospective, multicenter, randomized clinical trials in patients with coronary artery diseases and mild-to-moderate left ventricular dysfunction...
and in relevant places to be registered and used in Hong Kong. Further to the announcement of the 2023 Policy Address, a new "1+" mechanism was established to expedite the approval of new drugs and promote the development of clinical trials and research and development of drugs in Hong Kong...
We propose to begin the process of prototype development by creating a centralized calibration process for routine and critical analytes so that results collected during clinical trials will be equivalent regardless of the instrument or the laboratory. The aim is to eliminate the severe problems that ...
The primary data source: ClinicalTrials.gov ClinicalTrials.gov serves as a public repository for clinical trials carried out in the United States and abroad. The database contains pre-registration information, trial status, and results as provided by researchers conducting the trials. Many clinical ...
We discuss recent results from clinical trials and how these are likely to shape future practice and a renaissance of immunotherapy for renal cell cancer. Renal cell carcinoma (RCC) represents 2–3% of all adult cancers (Rini et al, 2009a). It is the seventh most common malignancy in men,...
Further research, however, is needed to assess the prevalence of different types of fraud, as well as its impact on the validity of results published in the medical literature. Control Clin Trials 2000;21:415–427 展开 DOI: 10.1016/S0197-2456(00)00069-6 被引量: 135 ...
Here, the authors develop a deep-learning algorithm to predict biomarkers from histopathological imaging in advanced urothelial cancer patients. This method detects suitable patients for targeted therapy clinical trials with a significant reduction in molecular testing, providing cost and time savings in re...